ASTROTECH Corp: Form 10-Q for the period ended Dec 31, 2012
Filed with the SEC on Feb 14, 2013 and accepted by EDGAR at Feb 14, 2013, 07:00 ET.
Management's discussion and analysis
As filed, 17,857 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following information should be read in conjunction with the unaudited condensed consolidated financial statements and the accompanying notes included in Part I, Item 1 of this Report, and the Risk Factors included in Part II Item 1A of this Report and Part I, Item 1A of our 2012 Annual Report on Form 10-K.
Overview
Astrotech was formed in 1984 to leverage the environment of space for commercial purposes. For nearly 30 years, the Company has remained a crucial player in space commerce activities. We have supported the launch of 23 shuttle missions and more than 300 spacecraft, built space hardware and processing facilities; constructed and operated world-class processing facilities; and prepared and processed scientific research for microgravity.
Our efforts are focused on:
Providing world-class facilities and related support services necessary for the preparation of satellites and payloads.
Providing satellite and payload processing and integration services and support.
Designing, fabricating and utilizing equipment and hardware for launch activities.
Supplying propellant and associated services for spacecraft.
Managing launch logistics and support.
Commercializing unique space-based technologies.
Our Business Units
Astrotech Space Operations (ASO)
ASO provides support to its government and commercial customers as they successfully process complex communication, earth observation and deep space satellites in preparation for their launch on a variety of launch vehicles. Processing activities include satellite ground transportation; pre-launch hardware integration and testing; satellite encapsulation, fueling, launch pad delivery; and communication linked launch control. Our ASO facilities can accommodate five meter class satellites, encompassing the majority of U.S.-based satellites. ASO’s service capabilities include designing and building spacecraft processing equipment and facilities. Additionally, ASO provides propellant services including designing, building and testing propellant service equipment for servicing spacecraft. ASO accounted for 99% of our consolidated revenues for the six months ended December 31, 2012. Revenue for our ASO business unit is generated primarily from various fixed-priced contracts with launch service providers in both the government and commercial markets and the design and fabrication of space launch equipment. The services and facilities we provide to our customers support the final assembly, checkout, and countdown functions associated with preparing and launching spacecraft. The revenue and cash flows generated from our ASO operations are primarily related to the number of spacecraft launches and the fabrication of the GSE for the U.S. Government. Other factors that have impacted, and are expected to continue to impact, earnings and cash flows for this business include:
The continuing limited availability of competing facilities at the major domestic launch sites that can offer comparable services, leading to an increase in government and commercial use of our services.
Our ability to design and fabricate spacecraft preparation and processing equipment.
Our ability to control our capital expenditures, which are primarily limited to modifications required to accommodate payload processing for new launch vehicles and upgrading building infrastructure.
Our ability to complete customer specified facility modifications within budgeted costs and time commitments.
Uncertainty in government funding and support for key space programs.
The impact of competition and industry consolidation and our ability to win new contracts.
Spacetech
Our other business unit is a technology incubator designed to commercialize space-industry technologies. This business unit is currently pursuing two distinct opportunities:
1st Detect
1st Detect designs, manufactures and sells miniature mass spectrometer equipment. 1st Detect launched the MMS-1000TM during March 2012. The MMS-1000TM is a low power, miniature mass spectrometer device designed initially for the laboratory testing market. The unique design of this unit is the result of the Company’s work with the National Aeronautics and Space Administration (“NASA”) on the International Space Station. 1st Detect has been awarded a Developmental Testing and Evaluation designation from the U.S. Department of Homeland Security as a “promising anti-terrorism technology,” and is the recipient of a Phase I and Phase II award from the U.S. Army’s Chemical and Biological Defense (“CBD”) Small Business Innovation Research (“SBIR”) Program. Following the successful execution of the Phase I SBIR, 1st Detect was awarded a $0.8 million Phase II SBIR contract from the Joint Science and Technology Office for Chemical and Biological Defense. Additionally, 1st Detect received a $1.8 million award from the Texas Emerging Technology Fund in March 2010.
Astrogenetix
Astrogenetix is a biotechnology company formed to commercialize products processed in the unique environment of microgravity. Astrogenetix pursued an aggressive space access strategy to take advantage of the Space Shuttle program prior to its retirement in 2011. This strategy gave Astrogenetix unprecedented access to research in microgravity, as the Company flew experiments twelve times over a three-year period. Astrogenetix is currently researching a Salmonella vaccine as part of its ongoing commercialization strategy. Concurrently, Astrogenetix is evaluating a vaccine target MRSA based on discoveries made in microgravity. In December 2011, the Company negotiated a Space Act Agreement with NASA for a minimum of twenty-eight future space flights.
Critical Accounting Policies
The discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with GAAP for interim financial statements. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Estimates and assumptions are reviewed periodically. Actual results may differ from these estimates under different assumptions or conditions.
Management believes there have been no significant changes during the period ended December 31, 2012 to the items that we disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our 2012 Annual Report on Form 10-K.
Results of Operation
Three months ended December 31, 2012 compared to three months ended December 31, 2011:
Selected consolidated financial data for the three months ended December 31, 2012 and 2011 is as follows (dollars in thousands):
| Three Months Ended December 31, 2012 | 2011 | |
|---|---|---|
| Revenue | $4,122 | $3,676 |
| Cost of revenue | 3,125 | 3,108 |
| Gross profit | 997 | 568 |
| Gross margin | 24% | 15% |
| Selling, general and administrative | 1,484 | 1,708 |
| Research and development | 393 | 746 |
| Operating expenses | $1,877 | $2,454 |
| Interest and other expense, net | (46) | (59) |
| Income tax expense | - | (7) |
| Consolidated net loss | $(926) | $(1,952) |
| Less: Net loss attributable to noncontrolling interest | (116) | (166) |
| Net loss attributable to Astrotech Corporation | $(810) | $(1,786) |
Revenue. Total revenue increased to $4.1 million for the three months ended December 31, 2012 from $3.7 million for the three months ended December 31, 2011. This increase is primarily attributable to the timing of mission launch dates.
Gross Profit. Gross profit increased to $1.0 million for the three months ended December 31, 2012 from $0.6 million for the three months ended December 31, 2011. This is attributable to our increase in revenue as our cost of revenue is generally near-term fixed-price for satellite payload processing.
Selling, General and Administrative Expense. Selling, general and administrative expense decreased to $1.5 million for the three months ended December 31, 2012 from $1.7 million for the three months ended December 31, 2011. The decrease was primarily attributable a reduction in headcount and employee incentive compensation expense.
Research and Development Expense. Research and development expense decreased to $0.4 million for the three months ended December 31, 2012 from $0.7 million for the three months ended December 31, 2011. This decrease is a result of the delivery and installation of two 1st Detect evaluation units to potential customers, which were recorded as an offset to research and development expense.
Six months ended December 31, 2012 compared to six months ended December 31, 2011:
Selected consolidated financial data for the six months ended December 31, 2012 and 2011 is as follows (dollars in thousands):
| Six Months Ended December 31, 2012 | 2011 | |
|---|---|---|
| Revenue | $10,251 | $8,516 |
| Cost of revenue | 8,032 | 6,034 |
| Gross profit | 2,219 | 2,482 |
| Gross margin | 22% | 29% |
| Selling, general and administrative | 3,583 | 3,637 |
| Research and development | 1,035 | 1,504 |
| Operating expenses | $4,618 | $5,141 |
| Interest and other expense, net | (85) | (133) |
| Income tax expense | - | (12) |
| Consolidated net loss | $(2,484) | $(2,804) |
| Less: Net loss attributable to noncontrolling interest | (257) | (352) |
| Net loss attributable to Astrotech Corporation | $(2,227) | $(2,452) |
17
Revenue. Total revenue increased to $10.3 million for the six months ended December 31, 2012 from $8.5 million for the six months ended December 31, 2011. This increase is primarily attributable to revenue earned on the fabrication of the GSE for the U.S. Government and propellant related services.
Gross Profit. Gross profit decreased to $2.2 million for the six months ended December 31, 2012 from $2.5 million for the six months ended December 31, 2011. The decline is the result of an increase in projects that contain lower profit margins.
Selling, General and Administrative Expense. Selling, general and administrative expense remained relatively the same at $3.6 million for the six month periods ended December 31, 2012 and 2011.
Research and Development Expense. Research and development expense decreased to $1.0 million for the six months ended December 31, 2012 from $1.5 million for the six months ended December 31, 2011. This decrease is a result of the delivery and installation of two 1st Detect evaluation units to potential customers, which was recorded as an offset to research and development expense.
Liquidity and Capital Resources
Our future capital requirements will depend on a number of factors, including our success in developing and expanding markets for our products, payments under possible future strategic arrangements, continued progress of our research and development of potential products, the need to acquire licenses to new technology, costs associated with increasing our manufacturing and development facilities, costs associated with strategic acquisitions including integration costs and assumed liabilities, litigation expense, the status of competitive products and potential cost associated with both protecting and defending our intellectual property. Additionally, actions taken as a result of the ongoing internal evaluation of our business could result in expenditures not currently contemplated in our estimates for 2013. We believe, however, that our existing cash and cash equivalents are sufficient to fund our operating expenses, capital equipment requirements and other expected liquidity requirements for the coming twelve months. Factors that could affect our capital requirements, in addition to those listed above include continued collections of accounts receivable consistent with our historical experience, uncertainly surrounding mission launch schedules, and our ability to manage product development efforts. See also the Risk Factors described in our 2012 Annual Report on Form 10-K filed with the Securities and Exchange Commission.
The following is a summary of the change in our cash and cash equivalents (in thousands):
| Six Months Ended December 31, 2012 | 2011 | |
|---|---|---|
| Net cash used in operating activities | $(4,506) | $(1,012) |
| Net cash used in investing activities | (588) | (253) |
| Net cash provided by (used in) financing activities | (145) | 723 |
| Net change in cash and cash equivalents | $(5,239) | $(542) |
Cash and Cash Equivalents
At December 31, 2012, we had cash and cash equivalents of $4.9 million and our working capital was approximately $2.6 million. As of December 31, 2011, we had cash and cash equivalents of $14.5 million and our working capital was approximately $5.9 million. Cash and cash equivalents have decreased by approximately $5.2 million during the six months ended December 31, 2012.
Operating Activities
Cash used in operations was $4.5 million for the six months ended December 31, 2012 compared to cash provided by operations of $1.0 million for the six months ended December 31, 2011. This decrease in cash flow was primarily attributable to an increase in accounts receivable and the timing of payments in accounts payable, which was attributable to the GSE project.
Investing Activities
Cash used in investing activities was $0.6 million for the six months ended December 31, 2012 compared to $0.3 million for the six months ended December 31, 2011. This increase was the result of capital expenditures for our payload processing facilities.
Financing Activities
Cash used by financing activities for the six months ended December 31, 2012 was $0.1 million compared to $0.7 million of cash provided by financing activities for the six months ended December 31, 2011. The cash provided through financing for the six months ended December 31, 2011 was the result of receiving the second installment of $0.9 million from the Texas Emerging Technology Fund, which did not reoccur in the six months ended December 31, 2012.
Debt
Credit Facilities
In October 2010, we entered into a financing facility with a commercial bank providing a $7.0 million term loan note and a $3.0 million revolving credit facility. The $7.0 million term loan terminates in October 2015, and the $3.0 million revolving credit facility expired in October 2012. The term loan requires monthly payments of principal plus interest at the rate of prime plus 0.25%, but not less than 4.0%. The revolving credit facility allowed multiple advances not to exceed $3.0 million, based on eligible accounts receivable, and incurred interest at the rate of prime plus 0.25%, but not less than 4.0%. The bank financing facilities are secured by the assets of ASO, including accounts receivable, and require us to comply with designated covenants. The balance of the $7.0 million term loan at December 31, 2012 was $6.2 million. In October 2012 the Company’s $3.0 million revolving credit facility expired. The Company had no outstanding balance on the revolving credit facility.
The Company was in compliance with all covenants as of December 31, 2012.
Income Taxes
The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that are more likely than not to be realized. As of December 31, 2012, the Company has established a full valuation allowance against all of its net deferred tax assets.
FASB ASC 740, Income Taxes (FASB ASC 740) addresses the accounting for uncertainty in income taxes recognized in an entity’s financial statements and prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken or expected to be taken on a tax return. As of December 31, 2012, the Company has a liability of $64,000 ($42,000 net of federal benefit) for unrecognized tax benefits.
For the six months ended December 31, 2012 and 2011, the Company’s effective tax rate differed from the federal statutory rate of 35%, primarily due to recording changes to the valuation allowance placed against its net deferred tax assets.
The Company files consolidated returns for federal, California, Florida, and Texas income and franchise taxes.
The Company is currently under examination by the Internal Revenue Service for the fiscal years ended June 30, 2008 through 2010. Loss carryovers are generally subject to modification by tax authorities until 3 years after they have been utilized; as such, the Company is subject to examination for the fiscal years ended 2000 through present for federal purposes and fiscal years ended 2006 through present for state purposes.
Off-Balance Sheet Arrangements
We do not have any significant off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.
Controls and procedures
As filed, 1,611 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (Exchange Act), which are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as of the end of the period covered by this Quarterly Report. Based on the evaluation and criteria of these disclosure controls and procedures, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective.
(b) Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Exchange Act Rule 13a-15(d) during the quarter ended December 31, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 1,683 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Other than the substitution of the following risk factor for the final risk factor in our 2012 Annual Report on Form 10-K, there have been no material changes in the risk factors described in our 2012 Annual Report on Form 10-K.
If our common stock ceases to be listed for trading on the NASDAQ Capital Market it may harm our stock price and make it more difficult to sell shares.
On November 13, 2012, we received written notification from NASDAQ indicating that the minimum bid price of our common stock had fallen below $1.00 for 30 consecutive trading days and that we were therefore not in compliance with NASDAQ Listing Rule 5550(a)(2). In order to regain compliance, the closing bid price of our common stock must be at least $1.00 per share for a minimum of ten consecutive business days. We cannot provide any assurance that we will be able to regain compliance with this requirement. Any delisting of our common stock from the NASDAQ Capital Market could adversely affect our ability to attract new investors, decrease the liquidity of our outstanding shares of common stock, reduce our flexibility to raise additional capital, reduce the price at which our common stock trades and increase the transaction costs inherent in trading such shares with overall negative effects for our shareholders. In addition, delisting of our common stock could deter broker-dealers from making a market in or otherwise seeking or generating interest in our common stock, and might deter certain institutions and persons from investing in our securities at all. For these reasons and others, delisting could adversely affect our business, financial condition and results of operations.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-10-01 to 2012-12-31 | $4.1m | us-gaap:Revenues |
| Revenue | 6 months2012-07-01 to 2012-12-31 | $10.3m | us-gaap:Revenues |
| Cost of revenue | 3 months2012-10-01 to 2012-12-31 | $3.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2012-07-01 to 2012-12-31 | $8.0m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2012-10-01 to 2012-12-31 | $997.0k | us-gaap:GrossProfit |
| Gross profit | 6 months2012-07-01 to 2012-12-31 | $2.2m | us-gaap:GrossProfit |
| Research and development | 3 months2012-10-01 to 2012-12-31 | $393.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2012-07-01 to 2012-12-31 | $1.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2012-10-01 to 2012-12-31 | $1.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2012-07-01 to 2012-12-31 | $3.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-10-01 to 2012-12-31 | −$880.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2012-07-01 to 2012-12-31 | −$2.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2012-10-01 to 2012-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2012-07-01 to 2012-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-10-01 to 2012-12-31 | −$810.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months2012-07-01 to 2012-12-31 | −$2.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-10-01 to 2012-12-31 | −$0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2012-07-01 to 2012-12-31 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-10-01 to 2012-12-31 | −$0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2012-07-01 to 2012-12-31 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-10-01 to 2012-12-31 | 19,428,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2012-07-01 to 2012-12-31 | 19,189,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2012-07-01 to 2012-12-31 | −$4.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2012-07-01 to 2012-12-31 | $588.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2012-12-31 | $4.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-12-31 | $9.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-12-31 | $46.4m | us-gaap:Assets |
| Current liabilities | At period end2012-12-31 | $6.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-12-31 | $12.7m | us-gaap:Liabilities |
| Long-term debt | At period end2012-12-31 | $5.8m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2012-12-31 | $380.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2012-12-31 | $33.7m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
Source: SEC EDGAR, the filing index for accession 0001515971-13-000053. Last ingested by Listed: Nov 14, 2026, 23:20 ET. Listed shows no prices and gives no investment advice.